← SynDRA
ABT-491
SynDRA canonical compound SYN0055561 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PTAFR |
|---|
| Mechanism of action | Platelet activating factor receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Platelet activating factor receptor antagonist
- PTAFR ANTAGONIST
- PTAFR MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- ABT-491 free base
- UNII-AYB44L739V
- AYB44L739V
- RefChem:108572
- DTXCID9091361
- ABT491
- GTPL1850
- SCHEMBL7496969
- BDBM50062054
- EX-A15343
- AKOS040750035
- NCGC00165735-01
- DA-18383
- A137491
- L000817
- BRD-K97233161-003-01-5
- 9EU
- abt-491 free base
- ABT 491
- N7IG7Z867J
- AKOS015889278
- ABT-491 hydrochloride, >=98% (HPLC)
- UNII-N7IG7Z867J
- DTXCID9094872
- FE103454
- A137491 hydrochloride
- orb1698801
- A 137491
- T29524
- SCHEMBL7943577
- AWRGBOKANQBIBM-UHFFFAOYSA-N
- RefChem:914909
- ABT 491 hydrochloride
- Abt 491
- SCHEMBL29766888
Look up ABT-491 in the interactive SynDRA portal →